Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Eir Ventures is a Nordic life sciences venture capital fund established to finance the development of innovative medicine. Founded in 2018, the organization operates from its offices in Stockholm, Sweden, and Copenhagen, Denmark. Eir Ventures aims to support companies and entrepreneurs that are pioneering transformative healthcare solutions, particularly in the biotech and healthcare sectors.
The firm has a strong emphasis on investing in high-potential life science opportunities, targeting both early-stage projects and more mature companies. Eir Ventures has built a portfolio of eight notable firms, showcasing its commitment to advancing healthcare innovation. The founding team comprises experienced professionals with MD and PhD qualifications, enhancing their expertise in the life sciences sector.
As of now, Eir Ventures manages a portfolio that reflects its strategic focus on balancing lower-risk investments with high-potential innovations. The firm has established itself as a key player in the Nordic venture capital landscape, particularly in the life sciences domain.
Eir Ventures invests primarily in the life sciences sector, with a specific focus on biotech and healthcare. The firm targets pre-seed, seed, and Series A stages, allowing it to engage with both nascent startups and more established companies. This investment strategy aims to balance lower-risk investments with high-potential innovations, ensuring a diverse portfolio that can withstand market fluctuations.
The organization emphasizes transformative potential, excellence in execution, and scalability when evaluating investment opportunities. Eir Ventures seeks to partner with entrepreneurs who are developing groundbreaking healthcare solutions that can significantly impact patient outcomes. Their geographic focus is primarily on Europe, particularly the Nordic region, where they believe the innovation landscape is ripe for investment.
Eir Ventures has made several notable investments in the life sciences sector, including:
This diverse portfolio highlights Eir Ventures' commitment to advancing innovative healthcare solutions and its strategic focus on high-potential life science opportunities.
Magnus Persson, Founding Partner, MD, PhD, Associate Professor. Magnus has extensive experience in the life sciences sector and has led numerous successful investments.
Amanda Hayward, Founding Partner, PhD. Amanda brings a strong academic background and expertise in biotech, contributing to the firm's investment strategy.
Stephan Christgau, Founding Partner, PhD. Stephan has a deep understanding of healthcare innovation and has been instrumental in shaping Eir Ventures' focus.
Tobias Horneman-Thielcke, Partner, MD, LLB. Tobias combines legal expertise with a medical background, enhancing the firm's operational capabilities.
Lovisa Backemar, Partner, MD, PhD. Lovisa's clinical experience and research background support Eir Ventures' commitment to advancing healthcare solutions.
What are Eir Ventures' investment criteria?
Eir Ventures focuses on high-potential life science opportunities, particularly in biotech and healthcare. They invest at pre-seed, seed, and Series A stages, targeting both early-stage projects and more mature companies.
How can I apply or pitch to Eir Ventures?
Founders can reach out to Eir Ventures through their website. A well-prepared pitch deck that outlines the business model, market opportunity, and team background is essential for consideration.
What makes Eir Ventures different from other investors?
Eir Ventures emphasizes transformative healthcare solutions and balances lower-risk investments with high-potential innovations. Their team comprises professionals with extensive experience in life sciences, enhancing their ability to support portfolio companies.
What is Eir Ventures' geographic scope?
The firm primarily focuses on investments in Europe, with a particular emphasis on the Nordic region, where they believe there are significant opportunities for innovation in life sciences.
What kind of post-investment involvement does Eir Ventures have?
Eir Ventures actively engages with its portfolio companies, providing mentorship and strategic guidance to help them scale and succeed in the competitive healthcare market.
What is the typical check size for investments?
While specific check sizes are not disclosed, Eir Ventures invests at pre-seed, seed, and Series A stages, indicating a range that accommodates early-stage funding needs.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.